Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Cryptogenic Organizing Pneumonia | 1 | 2016 | 35 | 0.63 | Why? |
| Idiopathic Pulmonary Fibrosis | 2 | 2018 | 595 | 0.45 | Why? |
| Pulmonary Aspergillosis | 1 | 2016 | 408 | 0.44 | Why? |
| Polymyxin B | 2 | 2020 | 93 | 0.40 | Why? |
| Indoles | 2 | 2018 | 1243 | 0.33 | Why? |
| Hemoperfusion | 2 | 2020 | 260 | 0.32 | Why? |
| Prednisolone | 2 | 2021 | 443 | 0.29 | Why? |
| Protein Kinase Inhibitors | 2 | 2014 | 1585 | 0.29 | Why? |
| Enzyme Inhibitors | 1 | 2014 | 1881 | 0.26 | Why? |
| HLA-B52 Antigen | 1 | 2021 | 13 | 0.23 | Why? |
| HLA-A11 Antigen | 1 | 2021 | 19 | 0.23 | Why? |
| Chemokine CCL17 | 1 | 2020 | 30 | 0.22 | Why? |
| Polystyrenes | 1 | 2020 | 98 | 0.20 | Why? |
| Pulmonary Alveolar Proteinosis | 1 | 2019 | 16 | 0.20 | Why? |
| HLA-C Antigens | 1 | 2021 | 195 | 0.20 | Why? |
| Yellow Nail Syndrome | 1 | 2018 | 5 | 0.19 | Why? |
| Bronchial Thermoplasty | 1 | 2017 | 14 | 0.18 | Why? |
| Clarithromycin | 1 | 2018 | 112 | 0.17 | Why? |
| Castleman Disease | 1 | 2017 | 28 | 0.17 | Why? |
| Nails | 1 | 2018 | 143 | 0.16 | Why? |
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2019 | 290 | 0.16 | Why? |
| Gene Frequency | 1 | 2021 | 1210 | 0.15 | Why? |
| Interferon-gamma Release Tests | 1 | 2017 | 253 | 0.15 | Why? |
| Voriconazole | 1 | 2016 | 206 | 0.14 | Why? |
| Hyperbaric Oxygenation | 1 | 2018 | 268 | 0.14 | Why? |
| Pneumonectomy | 1 | 2016 | 278 | 0.13 | Why? |
| Influenza A Virus, H5N1 Subtype | 1 | 2017 | 492 | 0.13 | Why? |
| Japan | 6 | 2021 | 6653 | 0.11 | Why? |
| Bucrylate | 1 | 2009 | 3 | 0.10 | Why? |
| ErbB Receptors | 1 | 2012 | 320 | 0.10 | Why? |
| Respiratory Insufficiency | 3 | 2021 | 7301 | 0.10 | Why? |
| Bronchial Arteries | 1 | 2009 | 30 | 0.10 | Why? |
| Salvage Therapy | 1 | 2012 | 417 | 0.10 | Why? |
| Interferon-gamma | 1 | 2017 | 2711 | 0.08 | Why? |
| Hemoptysis | 1 | 2009 | 172 | 0.08 | Why? |
| Military Personnel | 1 | 2017 | 1097 | 0.08 | Why? |
| Adrenal Cortex Hormones | 2 | 2021 | 6537 | 0.08 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 1573 | 0.08 | Why? |
| Embolization, Therapeutic | 1 | 2009 | 269 | 0.08 | Why? |
| Antifungal Agents | 1 | 2016 | 1828 | 0.07 | Why? |
| Autoimmune Diseases | 1 | 2019 | 1996 | 0.07 | Why? |
| Adenocarcinoma | 1 | 2012 | 651 | 0.07 | Why? |
| Biomarkers | 4 | 2021 | 23361 | 0.07 | Why? |
| Lung Diseases | 1 | 2017 | 2361 | 0.06 | Why? |
| Immunologic Factors | 1 | 2019 | 4206 | 0.06 | Why? |
| Administration, Inhalation | 2 | 2019 | 1647 | 0.06 | Why? |
| Male | 16 | 2021 | 367725 | 0.06 | Why? |
| Chronic Disease | 1 | 2016 | 5139 | 0.06 | Why? |
| Respiration, Artificial | 3 | 2021 | 22116 | 0.06 | Why? |
| Tuberculosis | 1 | 2017 | 2895 | 0.06 | Why? |
| Tomography, X-Ray Computed | 5 | 2021 | 25144 | 0.06 | Why? |
| beta 2-Microglobulin | 1 | 2020 | 102 | 0.05 | Why? |
| Kidney Transplantation | 1 | 2021 | 5397 | 0.05 | Why? |
| Anti-Bacterial Agents | 2 | 2020 | 10083 | 0.05 | Why? |
| Treatment Outcome | 5 | 2021 | 51732 | 0.05 | Why? |
| Radiography, Thoracic | 1 | 2016 | 5486 | 0.05 | Why? |
| Lung Neoplasms | 2 | 2018 | 3228 | 0.05 | Why? |
| Pulmonary Diffusing Capacity | 1 | 2019 | 191 | 0.05 | Why? |
| Aged | 11 | 2021 | 215776 | 0.05 | Why? |
| Arteries | 1 | 2020 | 283 | 0.05 | Why? |
| Asthma | 1 | 2017 | 4383 | 0.05 | Why? |
| Lymphedema | 1 | 2018 | 44 | 0.04 | Why? |
| Genetic Association Studies | 1 | 2021 | 559 | 0.04 | Why? |
| Humans | 22 | 2021 | 930598 | 0.04 | Why? |
| Haplotypes | 1 | 2021 | 853 | 0.04 | Why? |
| Blood Gas Analysis | 1 | 2020 | 893 | 0.04 | Why? |
| Glycine | 1 | 2018 | 203 | 0.04 | Why? |
| Walk Test | 1 | 2019 | 461 | 0.04 | Why? |
| Oxygen | 2 | 2020 | 3715 | 0.04 | Why? |
| Oximetry | 1 | 2021 | 658 | 0.04 | Why? |
| Acetylcysteine | 1 | 2018 | 255 | 0.04 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.04 | Why? |
| Retrospective Studies | 7 | 2021 | 105322 | 0.04 | Why? |
| Confidence Intervals | 1 | 2017 | 744 | 0.04 | Why? |
| Female | 12 | 2021 | 380317 | 0.04 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.03 | Why? |
| Administration, Oral | 1 | 2021 | 2340 | 0.03 | Why? |
| Immunoglobulin G | 1 | 2017 | 21571 | 0.03 | Why? |
| Pyridones | 1 | 2018 | 738 | 0.03 | Why? |
| Postoperative Care | 1 | 2018 | 755 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2019 | 2324 | 0.03 | Why? |
| Erlotinib Hydrochloride | 1 | 2012 | 48 | 0.03 | Why? |
| Pleural Effusion | 1 | 2018 | 680 | 0.03 | Why? |
| Influenza, Human | 1 | 2017 | 10779 | 0.03 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.03 | Why? |
| Meta-Analysis as Topic | 1 | 2018 | 1289 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Quinazolines | 1 | 2012 | 126 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2018 | 1755 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2018 | 2437 | 0.03 | Why? |
| Sinusitis | 1 | 2018 | 649 | 0.03 | Why? |
| History, 20th Century | 1 | 2017 | 1282 | 0.03 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.03 | Why? |
| Adult | 8 | 2020 | 244371 | 0.02 | Why? |
| Sulfonamides | 1 | 2018 | 1294 | 0.02 | Why? |
| Endothelium, Vascular | 1 | 2020 | 1751 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3633 | 0.02 | Why? |
| Recombinant Proteins | 1 | 2019 | 3786 | 0.02 | Why? |
| Cytokines | 2 | 2020 | 15010 | 0.02 | Why? |
| Risk | 1 | 2020 | 5288 | 0.02 | Why? |
| Double-Blind Method | 1 | 2019 | 5988 | 0.02 | Why? |
| Autoantibodies | 1 | 2019 | 2094 | 0.02 | Why? |
| Lung Diseases, Fungal | 1 | 2009 | 167 | 0.02 | Why? |
| Aged, 80 and over | 4 | 2020 | 88759 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Lung | 3 | 2021 | 31049 | 0.02 | Why? |
| Oxygen Inhalation Therapy | 1 | 2021 | 3629 | 0.02 | Why? |
| Quality of Health Care | 1 | 2018 | 1948 | 0.02 | Why? |
| Hypoxia | 1 | 2021 | 3626 | 0.02 | Why? |
| Smoking | 1 | 2019 | 3358 | 0.02 | Why? |
| Aspergillosis | 1 | 2009 | 264 | 0.02 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2018 | 3228 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| Arthritis, Rheumatoid | 1 | 2018 | 2043 | 0.02 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.02 | Why? |
| Intubation, Intratracheal | 1 | 2020 | 3962 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.02 | Why? |
| Sex Factors | 1 | 2021 | 11014 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Specimen Handling | 1 | 2021 | 6190 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.02 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.01 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 13720 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Immunosuppressive Agents | 1 | 2018 | 6331 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2017 | 8248 | 0.01 | Why? |
| Recurrence | 1 | 2009 | 3675 | 0.01 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.01 | Why? |
| Critical Illness | 1 | 2021 | 17281 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.01 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.01 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.01 | Why? |
| Time Factors | 1 | 2018 | 31397 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.01 | Why? |
| Young Adult | 1 | 2017 | 93724 | 0.00 | Why? |
Izumi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(141)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(188)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_